📰 Priya Singhal News
Page 2 - Priya Singhal News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Priya Singhal. Real-time updates on events, politics, business and more.
May 18, 2024
Fiera Capital Corp raised its holdings in Biogen Inc. (NASDAQ:BIIB – Free Report) by 11.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 15,076 shares of the biotechnology company’s stock after purchasing an additional 1,591 shares during the quarter. Fiera Capital Corp’s […]
May 16, 2024
Massachusetts Financial Services Co. MA boosted its holdings in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 29.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 580,065 shares of the biotechnology company’s stock after acquiring an additional 133,463 shares […]
May 5, 2024
Biogen (NASDAQ:BIIB – Get Free Report) had its price objective boosted by equities researchers at HSBC from $339.00 to $342.00 in a research report issued to clients and investors on Friday, Benzinga reports. The brokerage currently has a “buy” rating on the biotechnology company’s stock. HSBC’s price target would indicate a potential upside of 57.23% […]
May 4, 2024
Summit Global Investments purchased a new stake in Biogen Inc. (NASDAQ:BIIB – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 6,088 shares of the biotechnology company’s stock, valued at approximately $1,575,000. Several other institutional investors have also recently made changes to […]
May 4, 2024
Summit Global Investments bought a new position in Biogen Inc. (NASDAQ:BIIB – Free Report) in the fourth quarter, according to its most recent filing with the SEC. The firm bought 6,088 shares of the biotechnology company’s stock, valued at approximately $1,575,000. Several other large investors also recently bought and sold shares of BIIB. International Assets […]
May 3, 2024
Oppenheimer reissued their outperform rating on shares of Biogen (NASDAQ:BIIB – Free Report) in a research report report published on Monday morning, Benzinga reports. The brokerage currently has a $270.00 target price on the biotechnology company’s stock. Several other research analysts have also recently weighed in on the stock. Truist Financial reiterated a buy rating […]
April 30, 2024
Biogen Inc. (NASDAQ:BIIB – Get Free Report) has been given an average recommendation of “Moderate Buy” by the twenty-seven brokerages that are currently covering the firm, MarketBeat reports. Nine research analysts have rated the stock with a hold recommendation and eighteen have given a buy recommendation to the company. The average 1 year price objective […]
April 30, 2024
Investment House LLC lessened its holdings in Biogen Inc. (NASDAQ:BIIB – Free Report) by 2.0% in the 4th quarter, Holdings Channel.com reports. The firm owned 3,269 shares of the biotechnology company’s stock after selling 67 shares during the quarter. Investment House LLC’s holdings in Biogen were worth $846,000 as of its most recent SEC filing. […]
April 30, 2024
Investment House LLC reduced its holdings in Biogen Inc. (NASDAQ:BIIB – Free Report) by 2.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,269 shares of the biotechnology company’s stock after selling 67 shares during the quarter. Investment House LLC’s holdings in […]
April 28, 2024
Biogen (NASDAQ:BIIB – Free Report) had its target price upped by Wedbush from $213.00 to $215.00 in a report published on Thursday morning, Benzinga reports. They currently have a neutral rating on the biotechnology company’s stock. Wedbush also issued estimates for Biogen’s Q2 2024 earnings at $3.43 EPS, Q4 2024 earnings at $4.30 EPS, FY2024 […]